On ECHEMI
Home > Drugs > Neural tube defects in children
Neural tube defects in children
Neural tube defects (DNT) in children refer to deformities of the brain or spine of the child. When the neural tube closure process is affected during embryonic development within 3 months of pregnancy, abnormal development of the fetal brain or spinal cord will occur, which will lead to neural tube defects in children. DNT is one of the main causes of miscarriage and stillbirth in pregnant women, and is also one of the main causes of infant death and lifelong disability of patients. It not only affects the quality of the newborn population, but also threatens the physical and mental health of women and children, and imposes a heavy burden on families and society. DNT is an important public health issue worldwide, and China is a country with a high incidence of DNT in the world. At present, the prevention and treatment of DNT has been highly valued.
  • Site of disease:

    Cranio-spinal cord
  • Infectious :

    Not contagious
  • Frequent population:

    Children
  • Related symptoms:

    Slow growth polyuria convulsions open neural tube defect cleft lip
  • Concurrent disease:

Related Drugs
Potassium Chloride Injection
Indication: Electrolyte supplement. Used for: 1. Treatment of hypokalemia caused by various reasons. Such as insufficient food intake, vomiting, severe diarrhea, use of potassium-excreting diuretics, hypokalemic familial periodic paralysis, hypokalemia caused by long-term use of glucocorticoids and supplementation of hypertonic glucose, etc. 2. Prevention of hypokalemia. When the patient has potassium loss, especially if hypokalemia is harmful to the patient (such as patients using digitalis drugs), preventive potassium salt supplementation is required, such as eating very little, severe or chronic diarrhea, long-term use of adrenocortical hormones, potassium-losing nephropathy, Bartter syndrome, etc. 3. Frequent, multifocal premature beats or rapid arrhythmias caused by digitalis poisoning.
Manufacturer:

Zhejiang Tianrui Pharmacentical Industry Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.